Acurx - ACXP Net earnings per share growth forecast for next year

Corporate company logo of Acurx (ACXP)

Acurx Pharmaceuticals (ACXP) delegates antibiotic testing to specialized CROs while retaining all patents. Next year's earnings per share growth model visualizes the effect of this strategy, where the 14.60 metric indicates the status of expectations. The business relies on external CMOs for drug synthesis to avoid downtime and fully outsources production, remaining a flexible scientific team without capital expenditures.

ACXP: Acurx Pharmaceuticals Inc. Net earnings per share growth forecast for next year 07/04/2022 - 11/14/2026

ACXP (Acurx Pharmaceuticals Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart acurxpharma.com|ACXP - Fair Value Consensus
- issuer market value details:
Market Value Acurx Pharmaceuticals|ACXP - Total Enterprise Value
- company book value details:
Book Value per Share Acurx Pharmaceuticals|ACXP - Company Book Value|Market Capitalization to Book Value Ratio acurxpharma.com|ACXP - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Acurx Pharmaceuticals|ACXP - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Acurx|ACXP - Company Aggregate Debts|Debts to Book Capitalization Acurx|ACXP - Company Long-Term Liabilities|Company Current Liabilities Acurx Pharmaceuticals|Quick Liquidity acurxpharma.com
- earnings and valuation multiples information:
ACXP - Final Profit|Future Profit Acurx Pharmaceuticals|ACXP - Price to Earnings Multiple|Projected Price to Earnings acurxpharma.com|ACXP - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Acurx Pharmaceuticals, Inc.|ACXP - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Acurx Pharmaceuticals|ACXP - Earnings per share for the trailing year|Quarterly EPS earnings growth acurxpharma.com|ACXP - Earnings growth in current year|Net earnings per share growth forecast for next year Acurx Pharmaceuticals
- company sales and revenue statistics:
ACXP - Company Sales Revenue|Company Projected Revenue acurxpharma.com|ACXP - Market Cap to Revenue|Forward P/S Multiple Acurx Pharmaceuticals, Inc.
Basic company analysis:Acurx Pharmaceuticals Inc., ACXP
Core merchandise of Acurx Pharmaceuticals, Inc.

This indicator measures the expected earnings per share (EPS) dynamics, reflecting the market consensus regarding future profitability and the fundamental stability of the business. By analyzing the consensus forecast for forward-looking EPS growth rates, investors assess the capitalization potential of Acurx Pharmaceuticals (ACXP), which is supported by an efficient manufacturing outsourcing model via CMOs that eliminates capital expenditures for maintaining proprietary plants and the associated risks of operational downtime.

Analysis of competing companies

Net earnings per share growth forecast for next year Armata Pharmaceuticals